The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation.
Four common Lactobacillus strains were screened for their effects on proliferation of mouse splenic lymphocytes. Mice received perorally 10(9) viable bacteria kg(-1) body weight for 7 days. Lactobacillus acidophilus treatment enhanced ex vivo basal proliferation (by 43%) and B-cell response at suboptimal and optimal concentrations of lipopolysaccharide (LPS) (by 27-28%). Conversely, Lactobacillus casei, Lactobacillus gasseri and Lactobacillus rhamnosus inhibited both basal proliferation (by 14-51%) and mitogen-stimulated lymphoproliferation, particularly at supra-optimal concentrations of concanavalin A (by 43-68%) and LPS (by 23-62%). Therefore, these Lactobacillus strains demonstrate strain-specific effects on B- and T-cells and may also alter the splenocyte sensitivity to the cytotoxic effects of mitogens.
Kirjavainen
P V
PV
Key Centre for Applied and Nutritional Toxicology, RMIT-University, Melbourne, Vic., Australia. pirkka.kirjavainen@utu.fi
El-Nezami
H S
HS
Salminen
S J
SJ
Ahokas
J T
JT
Wright
P F
PF
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000284:Administration, Oral; D000818:Animals; D002455:Cell Division; D003208:Concanavalin A / Q000494:pharmacology; D007778:Lactobacillus; D007779:Lactobacillus acidophilus; D007780:Lacticaseibacillus casei; D008070:Lipopolysaccharides / Q000494:pharmacology; D008214:Lymphocytes / Q000166:cytology*; D008297:Male; D051379:Mice; D008934:Mitogens / Q000494:pharmacology; D019936:Probiotics / Q000008:administration & dosage / Q000494:pharmacology*; D013045:Species Specificity; D013154:Spleen / Q000166:cytology*
D000276:Adjuvants, Immunologic; D008070:Lipopolysaccharides; D008934:Mitogens; D003208:Concanavalin A